Rituximab hypersensitivity reactions and tolerance of ofatumumab therapy

Ali, SB; Yuson, C; Hissaria, P

Hissaria, P (corresponding author), Royal Adelaide Hosp, Dept Clin Immunol & Allergy, 1 Port Rd, Adelaide, SA 5000, Australia.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021; 39 (3): 648

Abstract

B-cell depleting agents play a key role in a variety of disease entities. Rituximab, a murine-human chimeric anti-CD20 monoclonal antibody, as one of ......

Full Text Link